CB - Q&A: early next year we'll have a renal product on the market, and expect a rapid and ramped up adoption of the product. We've been presenting to professionals in 20 conferences this year, the commercial force built around Illuccix will promptly contribute to that.
CB - Q&A: on the Pixclara front it's a very compact market. We have high degree of concentration in terms of customers. Again, adoption will be swift once we get approval. It's been also included in European guidelines and well-established clinical understanding. Expect at least 100'000 scans per year.
CB - Q&A: early next year we'll have a renal product on the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.45 |
Change
0.520(2.48%) |
Mkt cap ! $7.178B | |||
| Open | High | Low | Value | Volume |
| $20.83 | $21.50 | $20.80 | $17.54M | 824.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2037 | $21.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.50 | 12320 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |